PIIA LAVIKAINEN

Contact info

Keywords

Research groups - UEF

• 
  Pharmacoeconomics & Outcomes Research Group
• 
  StopDia
• 
  T2D-Data

Links

• Twitter @@LavikainenPiia
• Orcid Piia Lavikainen

Publications

• Koponen, Marjaana; Rajamaki, Blair; Lavikainen, Piia; Bell, J. Simon; Taipale, Heidi; Tanskanen, Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2022. Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer's Disease Journal of the american medical directors association [in press]: 1-7. 2022
• Alajärvi, Lasse; Timonen, Johanna; Lavikainen, Piia; Martikainen, Janne. 2021. Attitudes and Considerations towards Pharmaceuticals-Related Environmental Issues among Finnish Population Sustainability 13 22: 12930. 2021
• Inglin, Laura; Lavikainen, Piia; Jalkanen, Kari; Laatikainen, Tiina. 2021. LDL-cholesterol trajectories and statin treatment in Finnish type 2 diabetes patients: a growth mixture model Scientific reports 11 1: 22603. 2021
• Jalkanen, Kari; Aarnio, Emma; Lavikainen, Piia; Lindström, Jaana; Peltonen, Markku; Laatikainen, Tiina; Martikainen, Janne. 2021. Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis Bmc health services research 21 1: 916. 2021
• Lappalainen, Laura; Stenvall, Harriet; Lavikainen, Piia; Miettinen, Heikki; Martikainen, Janne; Sintonen, Harri; Tolppanen, Anna-Maija; Roine, Risto P; Hartikainen, Juha. 2021. Patient-reported outcomes in coronary artery disease: the relationship between the standard, disease-specific set by the International Consortium for Health Outcomes Measurement (ICHOM) and the generic health-related quality of life instrument 15D Health and quality of life outcomes 19 1: 206. 2021
• Martikainen, Janne; Jalkanen, Kari; Heiskanen, Jari; Lavikainen, Piia; Peltonen, Markku; Laatikainen, Tiina; Lindström, Jaana. 2021. Type 2 Diabetes-Related Health Economic Impact Associated with Increased Whole Grains Consumption among Adults in Finland Nutrients 13 10: 3583. 2021
• Ojala, Oona; Aarnio, Emma; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne; Lavikainen, Piia. 2021. Insuliinihoidon aloittamisen ajankohta ja perusteet ­ tyypin 2 diabetekseen sairastuneilla Lääkärilehti 76 1-2: 48-52. 2021
• Pisa, Federica; Reinold, Jonas; Lavikainen, Piia; Koponen, Marjaana; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2021. Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease Clinical epidemiology 13: 295-307. 2021
• Lavikainen, Piia; Aarnio, Emma; Jalkanen, Kari; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne. 2020. Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes Bmc health services research 20: 1095. 2020
• Lavikainen, Piia; Aarnio, Emma; Niskanen, Leo; Mäntyselkä, Pekka; Martikainen, Janne. 2020. Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes Health policy 124 12: 1310-1316. 2020
• Lavikainen, Piia; Koponen, Marjaana; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2020. Length of hospital stay for hip fracture and 30-day mortality in people with Alzheimer's disease: a cohort study in Finland Journals of gerontology series a: biological sciences and medical sciences 75 11: 2184-2192. 2020
• Sarycheva, Tatyana; Lavikainen, Piia; Taipale, Heidi; Tiihonen, Jari; Tanskanen, Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2020. Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease Neurology 94 20: e2099-e2108. 2020
• Tapiainen, V; Lavikainen, P; Koponen, M; Taipale, H; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, AM. 2020. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease Journal of the american geriatrics society 68 3: 595-602. 2020
• Lavikainen, Piia; Taipale, Heidi; Tanskanen, Antti; Koponen, Marjaana; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2019. Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease Journal of the american medical directors association 20 6: 751-758. 2019
• Kalamägi, J; Lavikainen, P; Taipale, H; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, AM. 2019. Predictors of high hospital care and medication costs and cost trajectories in community-dwellers with Alzheimer's disease Annals of medicine 51 5-6: 294-305. 2019
• Koponen, Marjaana; Lavikainen, Piia; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2019. Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease Journal of the american medical directors association 20 12: 1488-1494.e3. 2019
• Jalkanen, K; Aarnio, E; Lavikainen, P; Jauhonen, HM; Enlund, H; Martikainen, J. 2019. Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population Health and quality of life outcomes 17: 117. 2019
• Hamina, Aleksi; Lavikainen, Piia; Tanskanen, Antti; Tolppanen, Anna-Maija; Tiihonen, Jari; Hartikainen, Sirpa; Taipale, Heidi. 2018. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease INTERNATIONAL PSYCHOGERIATRICS 30 7: 947-956. 2018
• Sarycheva, Tatyana; Lavikainen, Piia; Taipale, Heidi; Tiihonen, Jari; Tanskanen; Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2018. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study Journal of the American Heart Association 7 18: e009742. 2018
• Sarycheva, Tatyana; Taipale, Heidi; Lavikainen, Piia; Tiihonen, Jari; Tanskanen, Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2018. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease Journal of Alzheimer's Disease 66 1: 387-395. 2018
• Tolppanen, Anna-Maija; Tiihonen, Miia; Taipale, Heidi; Koponen, Marjaana; Tanskanen, Antti; Lavikainen, Piia; Tiihonen, Jari; Hartikainen, Sirpa. 2018. Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study DRUGS & AGING 35 11: 985-992. 2018
• Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S. 2017. Antipsychotic use and the risk of hip fracture among community-dwelling persons with Alzheimer's disease. JOURNAL OF CLINICAL PSYCHIATRY 78 3: e257-e263. 2017
• Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa, Tolppanen Anna-Maija. 2017. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study Alzheimer's research and therapy 9 1: 59. 2017
• Taipale Heidi, Tolppanen Anna-Maija, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa. 2017. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling persons with Alzheimer's disease. CANADIAN MEDICAL ASSOCIATION JOURNAL 189 14: E519-E529. 2017
• Tolppanen A-M, Voutilainen A, Taipale H, Tanskanen A, Lavikainen P, Koponen M, Tiihonen J, Hartikainen S. 2017. Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011. PLOS ONE 12 3: e0173450. 2017
• Tolppanen A-M, Taipale H, Koponen M, Tanskanen A, Lavikainen P, Paananen J, Tiihonen J, Hartikainen S. 2017. Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26 8: 875-889. 2017
• Tolppanen Anna-Maija, Taipale Heidi, Koponen Marjaana, Lavikainen Piia, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa. 2016. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study. BMJ Open 6 7: e012100. 2016
• Tolppanen Anna-Maija, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa, Taipale Heidi. 2016. Psykoosilääkkeet yhteydessä Alzheimer-potilaiden keuhkokuumeriskiin. DUODECIM 132 16: 1490. 2016
• Tolppanen Anna-Maija, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa, Taipale Heidi. 2016. Antipsychotic use and risk of hospitalization or death due to pneumonia in persons with and without Alzheimer's disease. CHEST 150 6: 1233-1241. 2016
• Tolppanen Anna-Maija, Ahonen Riitta, Koponen Marjaana, Lavikainen Piia, Purhonen Maija, Taipale Heidi, Tanskanen Antti, Tiihonen Jari, Tiihonen Miia, Hartikainen Sirpa. 2016. Month and Season of Birth as a Risk Factor for Alzheimer's Disease: A Nationwide Nested Case-control Study. Journal of Preventive Medicine and Public Health 49 2: 134-138. 2016
• Koponen Marjaana, Taipale Heidi, Lavikainen Piia, Tanskanen Antti, Tiihonen Jari, Tolppanen Anna-Maija, Ahonen Riitta, Hartikainen Sirpa. 2016. Risk of Mortality associated with Antipsychotic Monotherapy and Polypharmacy among Community-Dwelling Persons with Alzheimer's Disease. Journal of Alzheimer's Disease 2017; 56 1: 107-118. 2016
• Lampela Pasi, Taipale Heidi, Lavikainen Piia, Hartikainen Sirpa. 2016. The effect of comprehensive geriatric assessment on anticholinergic exposure assessed by four ranked anticholinergic lists. ARCHIVES OF GERONTOLOGY AND GERIATRICS (LIMERICK) 68 (2017): 195-201. 2016
• Lavikainen Piia, Leskinen Esko, Hartikainen Sirpa, Möttönen Jyrki, Sulkava Raimo, Korhonen Maarit J.. 2015. Impact of missing data mechanism on the estimate of change: a case study on cognitive function and polypharmacy among older persons. Clinical Epidemiology 7: 169-180. 2015
• Laitinen Marja-Liisa, Lönnroos Eija, Bell J. Simon, Lavikainen Piia, Sulkava Raimo, Hartikainen Sirpa. 2014. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study. INTERNATIONAL PSYCHOGERIATRICS 2015; 27 4: 669-672. 2014
• Lampela Pasi, Lavikainen Piia, Garcia-Horsman J. Arturo, Bell J. Simon, Huupponen Risto, Hartikainen Sirpa. 2013. Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study. DRUGS & AGING 30 5: 321-330. 2013
• Lampela Pasi, Lavikainen Piia, Huupponen Risto, Leskinen Esko, Hartikainen Sirpa. 2013. Comprehensive geriatric assessment decreases prevalence of orthostatic hypotension in older persons. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH 41: 351-358. 2013
• Puolakka Elina, Aaltonen Katri, Lavikainen Piia, Hartikainen Sirpa. 2013. Ei-korvattavien lääkkeiden käyttö kuopiolaisilla iäkkäillä vuonna 2007. DOSIS : FARMASEUTTINEN AIKAKAUSKIRJA 29 3: 153-163. 2013
• Tolppanen A-M, Lavikainen P, Soininen H, Hartikainen S. 2013. Incident Hip Fractures among Community Dwelling Persons with Alzheimer's Disease in a Finnish Nationwide Register-Based Cohort. PLOS ONE [ONLINE] 8 3: e59124. 2013
• Tolppanen Anna-Maija, Lavikainen Piia, Solomon Alina, Kivipelto Miia, Soininen Hilkka, Hartikainen Sirpa. 2013. Incidence of stroke in people with Alzheimer disease. A national register-based approach. NEUROLOGY 80 4: 353-358. 2013
• Tolppanen Anna-Maija, Lavikainen Piia, Solomon Alina, Kivipelto Miia, Uusitupa Matti, Soininen Hilkka, Hartikainen Sirpa. 2013. History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study. DIABETES CARE 36: 2015-2019. 2013
• Tolppanen Anna-Maija, Taipale Heidi, Koponen Marjaana, Lavikainen Piia, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa. 2013. Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study. Clinical Epidemiology 5: 277-285. 2013
• Lihavainen Katri, Sipilä Sarianna, Rantanen Taina, Seppänen Jarmo, Lavikainen Piia, Sulkava Raimo, Hartikainen Sirpa. 2012. Effects of comprehensive geriatric intervention on physical performance among people aged 75 years and over. Aging Clinical and Experimental Research 24: 331-338. 2012
• Saastamoinen Leena K, Wallin Mika, Lavikainen Piia, Airaksinen Marja S, Sourander Andre, Bell J. Simon. 2012. Treatment duration with selective serotonin reuptake inhibitors among children and adolescents in Finland: a nationwide register study. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 68 7: 1109-1117. 2012
• Desplenter Franciska, Lavikainen Piia, Hartikainen Sirpa, Sulkava Raimo, Bell J. Simon. 2012. Sedative use and incident cognitive decline among persons aged 75 years and older: a population-based longitudinal study. INTERNATIONAL PSYCHOGERIATRICS 24 1: 48-54. 2012
• Bell J Simon, Ahonen Jouni, Lavikainen Piia, Hartikainen Sirpa. 2012. Potentially inappropriate drug use among older persons in Finland: application of a new national categorization. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2013:69: 657-664. 2012
• Bell J Simon, Laitinen Marja-Liisa, Lavikainen Piia, Lönnroos Eija, Uosukainen Hanna, Hartikainen Sirpa. 2011. Use of strong opioids among community-dwelling persons with and without Alzheimer's disease in Finland PAIN 152: 543 - 547. 2011
• Bell J Simon, Lavikainen Piia, Korhonen Mikko, Hartikainen Sirpa. 2011. Benzodiazepine discontinuation among community-dwelling older people: a population-based cohort study. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 67: 105 - 106. 2011
• Bell J Simon, Lönnroos Eija, Koivisto Anne M, Lavikainen Piia, Laitinen Marja-Liisa, Soininen Hilkka, Hartikainen Sirpa. 2011. Use of antiepileptic drugs among community-dwelling persons with Alzheimer's disease in Finland. Journal of Alzheimer's Disease 26: 231-237. 2011
• Jyrkkä Johanna, Enlund Hannes, Lavikainen Piia, Sulkava Raimo, Hartikainen Sirpa. 2011. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 20: 514 - 522. 2011
• Laitinen Marja-Liisa, Bell Simon, Lavikainen Piia, Lönnroos Eija, Sulkava Raimo, Hartikainen Sirpa. 2011. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland INTERNATIONAL PSYCHOGERIATRICS 23 10: 1623-1631. 2011
• Ruokoniemi P, Korhonen MJ, Helin-Salmivaara A, Lavikainen P, Jula A, Junnila SY, Kettunen R, Huupponen R.. 2011. Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 71 5: 766-776. 2011
• Aaltonen K, Lavikainen P, Bell JS & Hartikainen S. 2010. Mitä ei-korvattuja lääkkeitä yli 75-vuotiaat kuopiolaiset käyttävät?, Farmasian Päivät 19. - 21.11.2010 Ratkaisuja tulevaisuuteen - Bringar nytt i dagen. 92-93. 2010
• Helin-Salmivaara Arja, Lavikainen Piia T, Korhonen Maarit J, Halava Heli, Martikainen Jaana E, Saastamoinen Leena K, Virta Lauri, Klaukka Timo, Huupponen Risto. 2010. Pattern of statin use among 10 cohorts of new users from 1995 to 2004: a register-based nationwide study The American Journal of Managed Care 16 2: 116-122. 2010
• Ilomäki J, Korhonen MJ, Lavikainen P, Lipton R, Enlund H & Kauhanen J. 2010. Changes in alcohol consumption and drinking patterns during 11 years of follow-up among ageing men: the FinDrink study. EUROPEAN JOURNAL OF PUBLIC HEALTH 20 2: 133 - 138. 2010
• Lampela P, Hartikainen S, Lavikainen P, Sulkava R & Huupponen R. 2010. Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study. DRUGS & AGING 27 6: 507-521. 2010
• Saastamoinen LK, Wallin M, Lavikainen P, Airaksinen MS & Bell JS. 2010. Persistence with selective serotonin reuptake inhibitor treatment among children and adolescents in Finland: a nationwide register study. Oral communicatios, 16th International Social Pharmacy Workshop 23.-26.8.2010 Lisboa, Portugal. Pharmacy Practice (Internet) Vol. 8 (suppl 1). 62-63. 2010
• Tuikkala P, Hartikainen S, Korhonen MJ, Lavikainen P, Kettunen R, Sulkava R & Enlund H. 2010. Serum total cholesterol levels and all-cause mortality in a home-dwelling elderly population: a six-year follow-up SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE 28: 121-127. 2010
• Hartikainen S, Lavikainen P, Raunio H, Ahonen J, Peura P, Martikainen J, Klaukka T. 2009. Mahahaavalääkitys pienemmin kustannuksin. SUOMEN LÄÄKÄRILEHTI 64 4: 296-299. 2009
• Helin-Salmivaara A, Lavikainen P, Ruokoniemi P, Korhonen Maarit, Huupponen R. 2009. Persistence with statin therapy in diabetic and non-diabetic persons. a nation-wide register study in 1995-2005 in Finland. DIABETES RESEARCH AND CLINICAL PRACTICE 84: e9-e11. 2009